Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Nephrology and urology devices are medical devices used to treat kidney and urinary system diseases such as chronic kidney disease (CKD), urinary incontinence and prolapse of pelvic organs, kidney stones, hyperplasia benign prostate (BPH) and end stage renal disease (ESRD). According to the WHO, more than 190 million patients suffer from chronic kidney failure and suffer a kidney, and more than 220 million men suffer from diseases associated with the prostate glands such as swelling that leads to blocking the urine flow through the body. These growing implications of renal and urological diseases have changed the tendency of doctors to use very advanced nephrology and urology which considerably shorten the treatment and recovery time. The main driving factor in this market is the growing aging population and the prevalence of chronic kidney disease. Innovations in urology systems and an increase in use of high-tech nephrology devices are also factors that are anticipated to provide ample new growth opportunities for the market over the upcoming years.
The high incidences of chronic kidney diseases (CKDs) coupled with the rising number of elderly population is a key rendering driving factor for the market. The National Kidney Foundation estimates that chronic kidney disease affects 10.0% of the world's population. The growing patient population is seeking treatment for this disorder, increasing the overall demand for nephrology and urology devices. The growing incidence of diabetes and high blood pressure (blood pressure) also contributes to the growth of this industry, as these two diseases are the main reasons for kidney failure. According to data published by the American Nayney Fund, 38.4% of kidney failure is due to diabetes and 25% of kidney failure is due to high blood pressure. This strong correlation between renal failure and the above diseases is expected to stimulate the growth of the market.
In addition, the market is expected to be driven by a large geriatric population, highly susceptible to various diseases, including kidney and urinary tract disorders. According to the WHO, the global population aged 65 and over is projected to increase from 7% in 2000 to 16% in 2050. Old age is considered one of the major risk factors for developing various medical conditions. Aging also weakens the immune system and consequently increases the patient's susceptibility to various conditions such as kidney disease, diabetes, prostate cancer, and urinary retention. According to the American Society of Nephrology, urological diseases are the third most common concern among the geriatric population, accounting for approximately 47% of doctor visits. Therefore, the increase in the geriatric population is one of the key drivers for the market in the forecast period.
The growing demand for minimally invasive procedures resulting from recent technological innovations is expected to increase the sales of nephrology and urology devices in the market. The nephrology and urology devices such as ureteral stents, catheters, guidewires and renal dilators are developed using advanced materials such as nitinol, polyurethanes/polycarbonates and silicones. Carbothane is a material that is resistant to various chemicals, such as iodine, hydrogen peroxide or alcohol, which extends its life. The use of advanced materials during production offers several advantages such as improved strength and resistance, increasing the demand for the devices and stimulating the growth of the industry this factor is expected to provide rising new growth opportunities for the market over the forecast period.
The market has a key restraint factor like the high cost of most urology devices and this factor is expected to act as a hurdle for the market’s growth over the forecast period. There is a high degree of competition among the market players. Only large companies can afford high capital investments, as well as the high costs of R&D and production. This prevents new entrants from entering this market. Newcomers in this market have to compete with existing players and differentiate themselves by developing an innovative product range. The high degree of consolidation represents an important barrier to entry for new entrants, who in turn are expected to limit investment and thus slow down the growth potential of this market.
There are several market challenges that affect the growth of the market. One of the biggest challenges in the hospital sector is the absence of specialized urological hospitals. There are many multi-specialty hospitals and general hospitals present in the healthcare scenario. However, the number of urology hospitals is decreasing. As the largest customers in the urology device market are specialty hospitals, there is a need to increase the number of such hospitals to support the growth of nephrology and urology devices.
The report provides an in-depth analysis of the global Nephrology and Urology Devices market, market size, and compound annual growth rate (CAGR) for the forecast period of 2023-2029, considering 2022 as the base year. With increasing demand for various nephrology and urology devices in various applications has led the increasing demand for market and is expected to witness the growth at a specific CAGR from 2023-2029.
The global Nephrology and Urology Devices market comprises of different market segments like product, application, end users and geography.
By product, the Nephrology and Urology Devices includes the key segments of
The percutaneous nephrostomy (PCN) catheters segment is expected to expand at the highest CAGR owing to its numerous applications in urological disorders such as treatment of renal transplant complications, decompression of the perinephric or nephric fluid collection, and nondilated obstructive therapy. Thus, the increasing prevalence of urological diseases, such as cervical cancer, and the benefits offered by PCN catheters are expected to drive the market.
The other segment is expected to grow at the fastest rate due to the high prevalence of prostate and colorectal cancer, AKI and urolithiasis and the introduction of technologically advanced products by major players. For example, according to the National Health Service (NHS) England, around 61.0% of the male population suffer from lower urinary tract infections and over 34.0% of women live with some type of urinary incontinence. Additionally, the increasing prevalence of conditions such as high blood pressure and diabetes indicates a higher risk for people with kidney disease, as these two diseases are major risk factors for kidney disease. Hence, the rising prevalence of these diseases is expected to drive the growth of the segment.
The Nephrology and Urology Devices market has key applications in
The kidney disease segment is expected to account for the largest share of the market. The increasing prevalence of kidney diseases coupled with associated health complications is driving the demand for urological procedures to treat them, which in turn is driving the market for urological devices. Growing geriatric population is another key driver for the growth of the market, as elderly people are more prone to chronic diseases such as diabetes and hypertension which are major contributors to kidney disease (CKD and ESRD).
Similarly, urological cancer and BPH are likely to grow at a high rate over the estimated time period due to the increase in prevalence of urological cancer all over the world.
The Nephrology and Urology Devices market has major end users like
This hospitals and clinics segment is expected to grow at the highest CAGR during the forecast period. The large share of this segment is due to the increase in hospital spending on treatment of urological diseases and the demand for advanced treatments which are currently only offered by hospitals and multispecialty clinics.
Likewise, the ambulatory surgical centers segment is expected to grow at a moderately high rate during the estimated time period. There is a high demand for nephrological devices with respect to various cancer surgery procedures. Also ambulatory surgical centers provide a favourable reimbursement option. These factors are anticipated to contribute to healthy growth for the segment over the forecast period
The global Nephrology and Urology Devices market is studied for the following regions
North America is expected to account for the largest share of the market due to an increase in the prevalence of kidney-related diseases, increasing government treatment initiatives, highly qualified physicians and the presence of well-established healthcare facilities. In addition, increasing research funding for the development of advanced devices is positively affecting industry growth in this region. In addition, the rising prevalence of diabetes and hypertension increases the risk of developing urological and nephrological diseases, which is expected to further increase the demand for nephrological and urological devices in this region.
The Asia-Pacific region is expected to witness significant growth due to various factors such as increasing awareness of kidney and urinary tract diseases, increasing healthcare spending and improving healthcare facilities in this region. The increasing prevalence of benign prostatic hyperplasia (BPH), spinal cord injuries and urinary tract infections (UTI) is driving the Asia Pacific market. UTI is one of the most common infectious diseases in this region. In addition, the urgent need for the development of new systems and the replacement and upgrading of existing medical infrastructure are other factors that contribute to the growing demand for these devices.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the global Nephrology and Urology Devices market. In addition, complete analysis of changes on the global Nephrology and Urology Devices market expenditure, economic and international policies on supply and demand side. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP and the marketing strategies of key players present in the market.
COVID-19 pandemic is expected to have a moderate impact on industry growth in the near term. The impact of the epidemic on the market varies from country to country, depending on local health systems and the measures taken to combat the pandemic. Urological surgeries were considered non-urgent during the pandemic. For this reason, all outpatient and elective interventional procedures were reduced or stopped to reduce the risk. During this period the specialized centers for dialysis and related services were also closed, with a further negative impact on the growth of the sector. However, as lockdown restrictions are lifted in most countries, the supply chains of most healthcare companies are expected to operate effectively and smoothly during the forecast period. The global market is therefore expected to grow significantly in the coming years.
The competitive landscape analysis of Nephrology and Urology Devices market is majorly focused on expanding the global growth of nephrology and urology devices through new product innovation, business expansion, increasing presence of a range of manufacturers operating in nephrology and urology devices has led to growing demand for the market. Besides, the market offers a range of products in different applications to fulfil the required demand of consumers, which is further contributing to healthy growth in the market.
The key players studied in market are
November 2020: Baxter International Inc. had received 510(k) approval from the FDA for its Homechoice Claria automated peritoneal dialysis system with the Sharesource connectivity platform.
July 2020: Baxter International had expanded its partnership with Ayogo Health Inc. to combine the latter’s LifePlan behavior-based digital platform with Baxter’s renal care expertise to build mobile apps and digital solutions to support kidney failure patients.
By product, the Nephrology and Urology Devices market includes the key segments of ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, renal dilators and others. The PCN catheters is expected to dominate the market over the forecast period. The Nephrology and Urology Devices market has key applications in urolithiasis, urological cancer and BPH, bladder disorders, kidney diseases and others. The kidney diseases segment is expected to have growth in the market over the forecast period. The Nephrology and Urology Devices market has major end users like hospitals and clinics, ambulatory surgical centers. This hospitals and clinics segment is expected to grow at the highest CAGR during the forecast period.
The global Nephrology and Urology Devices market is studied for the following region North America, Europe, Asia-Pacific and Rest of the World (RoW). North America is expected to account for the largest share in the market due to an increase in the prevalence of kidney-related diseases, increasing government treatment initiatives, highly qualified physicians and the presence of well-established healthcare facilities.
| Market Sizing for Year: | 2019-2029 |
| Base Year: | 2022 |
| Forecast Period: | 2023-2029 |
| Value: | USD
Million |
| Market Segment studied: | Product Application End Users |
| Market Players and its Competitors: | Boston Scientific Corporation Baxter International Fresenius Medical Care Nikkiso Co. Ltd Dornier Medtech C.R.Bard Hollister Incorporated Medtronic Coloplast ConvaTec Group B. Braun AG Teleflex Inc. Asahi Kasei Corp. Cook Group Terumo Corporation |
FREQUENTLY ASKED QUESTIONS
What would be forecast period in the market report?
2023-2029 is the forecast period in the market report.
Which is the leading application segment for Nephrology and Urology Devices market?
Kidney Diseases has accounted the major market share, and is expected to witness the growth at highest pace during the forecast period.
Which region is gaining majority of market share during the forecast period (2023-2029)?
North America is expected to gain major market share during the forecast period (2023-2029).
